Rentschler Biopharma is a leading contract development and manufacturing organization (CDMO) focused exclusively on client projects. The company offers process development and manufacturing of biopharmaceuticals, including adeno-associated virus (AAV) gene therapies, as well as related consulting activities, project management and regulatory support.
Microbiology Product Areas
Pharmaceutical
Adeno-associated virus (AAV)
Show all suppliersATMP - Advanced Therapeutic Medicinal Products
Show all suppliersCell and Gene Therapies
Show all suppliersContract Research Organization (CRO)
Show all suppliersGene and Cell Therapies
Show all suppliers
advertisement
advertisement
advertisement
advertisement
advertisement
LATEST MICROBIOLOGY NEWS
MICROBIOLOGY EVENTS
-
2025 ISPE Pharma 4.0™ Conference
-
Endotoxin Masterclass: Comprehensive Training in Modern Testing Methods
-
Validate Your 2nd Culture Media Supplier and Eliminate Single-Source Risk
-
LIMS Launchpad Webinar Series: Episode #6 - Overview and Expert Roundtable
-
10th Anniversary Microbiome Movement Summit
-
WHX Labs Dubai
-
World Water-tech Innovation Summit
-
2026 QC Micro Summit
-
Analytica 2026
-
ESCMID Global 2026
